The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae

Clin Infect Dis. 1996 Jan;22(1):165-7. doi: 10.1093/clinids/22.1.165.


One possible explanation for the apparently reduced efficacy of pneumococcal vaccine in elderly subjects is that IgG responses to pneumococcal capsular polysaccharides (PPSs) decline with aging. We administered pneumococcal vaccine to 118 adults who ranged in age from 20 to 93 years; 33 were > or = 70 years old. Four to 6 weeks later, we measured IgG reactive with PPSs from 10 commonly infecting serotypes of Streptococcus pneumoniae. By regression analysis, a slight but nonsignificant increase in anti-PPS IgG was observed with increased age for six serotypes and a nonsignificant decrease was observed for four. Mean IgG levels and the percentage of subjects with IgG levels > or = 1 microgram/mL were no different among persons > or = 70 years of age than among those < or = 69 years of age. These results show no consistent effect of aging on anti-PPS IgG levels 4-6 weeks after pneumococcal vaccination.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / immunology*
  • Antibodies, Bacterial / blood*
  • Antibodies, Bacterial / immunology
  • Bacterial Capsules / immunology*
  • Bacterial Vaccines / immunology*
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology*
  • Middle Aged
  • Streptococcus pneumoniae / immunology*
  • Vaccination


  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Immunoglobulin G